New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 29, 2020 - Menlo Therapeutics announced the FDA approval of Zilxi (minocycline) topical foam, for the treatment of inflammatory lesions of rosacea in adults.
Download PDF
Return to publications
